Detalhe da pesquisa
1.
Recurrent PTPRZ1-MET fusion and a high occurrence rate of MET exon 14 skipping in brain metastases.
Cancer Sci
; 113(2): 796-801, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-34812554
2.
Tumor microenvironment is associated with clinical and genetic properties of diffuse gliomas and predicts overall survival.
Cancer Immunol Immunother
; 71(4): 953-966, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-34535804
3.
Predicting the likelihood of postoperative seizure status based on mRNA sequencing in low-grade gliomas.
Future Oncol
; 14(6): 545-552, 2018 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-29206064
4.
RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas.
Genome Res
; 24(11): 1765-73, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-25135958
5.
A single aspergillus fumigatus intracranial abscess in an immunocompetent patient with parietal lobe tumorectomy.
World J Surg Oncol
; 12: 181, 2014 Jun 07.
Artigo
Inglês
| MEDLINE | ID: mdl-24906819
6.
[Whole-genome messenger RNA profiling reveals genes involved in malignant progression of glioma].
Zhonghua Yi Xue Za Zhi
; 93(1): 5-7, 2013 Jan 01.
Artigo
Chinês
| MEDLINE | ID: mdl-23578443
7.
Comprehensive analysis of multi-omics data of recurrent gliomas identifies a recurrence-related signature as a novel prognostic marker.
Am J Cancer Res
; 11(4): 1226-1246, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33948355
8.
Mutation and Copy Number Alterations Analysis of KIF23 in Glioma.
Front Genet
; 12: 646929, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34017355
9.
MET overexpression contributes to STAT4-PD-L1 signaling activation associated with tumor-associated, macrophages-mediated immunosuppression in primary glioblastomas.
J Immunother Cancer
; 9(10)2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34667077
10.
Clinical and Molecular Characterization of Incidentally Discovered Lower-Grade Gliomas with Enrichment of Aerobic Respiration.
Onco Targets Ther
; 13: 9533-9542, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-33061437
11.
Whole-transcriptome sequencing profiling identifies functional and prognostic signatures in patients with PTPRZ1-MET fusion-negative secondary glioblastoma multiforme.
Oncol Lett
; 20(5): 187, 2020 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-32952656
12.
Prognostic Correlation of Autophagy-Related Gene Expression-Based Risk Signature in Patients with Glioblastoma.
Onco Targets Ther
; 13: 95-107, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32021258
13.
PD-L2 expression is correlated with the molecular and clinical features of glioma, and acts as an unfavorable prognostic factor.
Oncoimmunology
; 8(2): e1541535, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-30713802
14.
Immune Cytolytic Activity Is Associated With Genetic and Clinical Properties of Glioma.
Front Immunol
; 10: 1756, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31428092
15.
Risk factors and the prognosis of sexual dysfunction in male patients with pituitary adenomas: a multivariate analysis.
Asian J Androl
; 20(1): 43-49, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-28816201
16.
Overexpression of Paxillin Correlates with Tumor Progression and Predicts Poor Survival in Glioblastoma.
CNS Neurosci Ther
; 23(1): 69-75, 2017 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-27637748
17.
Phosphohistone H3 (pHH3) is a prognostic and epithelial to mesenchymal transition marker in diffuse gliomas.
Oncotarget
; 7(29): 45005-45014, 2016 Jul 19.
Artigo
Inglês
| MEDLINE | ID: mdl-27323851
18.
Enhanced expression and phosphorylation of the MET oncoprotein by glioma-specific PTPRZ1-MET fusions.
FEBS Lett
; 589(13): 1437-43, 2015 Jun 04.
Artigo
Inglês
| MEDLINE | ID: mdl-25935522
19.
Identification of high risk anaplastic gliomas by a diagnostic and prognostic signature derived from mRNA expression profiling.
Oncotarget
; 6(34): 36643-51, 2015 Nov 03.
Artigo
Inglês
| MEDLINE | ID: mdl-26436699
20.
Correlation of IDH1/2 mutation with clinicopathologic factors and prognosis in anaplastic gliomas: a report of 203 patients from China.
J Cancer Res Clin Oncol
; 140(1): 45-51, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-24149775